Clinigen Group (CLIN)

Sector:

Food Pharmacy Retail

Index:

FTSE AIM 50

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

925.00p
   
  • Change Today:
    -17.00p
  • 52 Week High: 1,110.00
  • 52 Week Low: 815.00
  • Currency: UK Pounds
  • Shares Issued: 132.19m
  • Volume: 292,548
  • Market Cap: 1,222.77m
  • Beta: 1.00

Clinigen Group Overview

Clinigen Group is in the food pharmacy retail sector and is currently trading at 925.00p per share. In the last year Clinigen Group's share price has ranged from 815.00p to 1,110.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (12-11-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.6% 0.7%
Div Cover 8.1 8.5
Op Mrgn 10.9% 19.5%
ROCE 75.9%  
Latest F'cast
P/E 20.4 17.6
PEG 2.1 1.1
Pr/Revenue 3.2 2.7
Pr/Book 3.5  
Latest F'cast
Revenue 26.1% 17.4%
PBT 154.6% 143.4%
EPS 9.9% 16.1%
DPS 12.0% 11.1%

Clinigen Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-14 126.64 21.24 24.50p 15.4 1.5 +10% 3.10p 0.8%
30-Jun-15 184.40 8.30 28.00p 22.3 1.6 +14% 3.40p 0.5%
30-Jun-16 339.90 15.90 33.40p 18.1 1.0 +19% 4.00p 0.7%
30-Jun-17 302.30 14.10 41.30p 20.8 0.9 +24% 5.00p 0.6%
30-Jun-18 381.20 35.90 45.40p 20.2 2.0 +10% 5.60p 0.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Clinigen Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 447.48 87.39 52.69p 17.6 1.1 +16% 6.22p 0.7%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Clinigen Group Company Announcements

Result of AGM 08-Nov-2018 15:39 RNS
Grant of Share Options and PDMR notification 01-Nov-2018 09:52 RNS
Total Voting Rights 31-Oct-2018 09:00 RNS

Latest Clinigen Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Clinigen Group Market Data

Currency UK Pounds
Share Price 925.00p
Change Today -17.00p
% Change -1.80 %
52 Week High 1,110.00
52 Week Low 815.00
Volume 292,548
Shares Issued 132.19m
Market Cap 1,222.77m
Beta 1.00

Clinigen Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.79% below the market average87.79% below the market average87.79% below the market average87.79% below the market average87.79% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Price Trend
49.12% above the market average49.12% above the market average49.12% above the market average49.12% above the market average49.12% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average
Income
49.51% below the market average49.51% below the market average49.51% below the market average49.51% below the market average49.51% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
79.81% above the market average79.81% above the market average79.81% above the market average79.81% above the market average79.81% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Clinigen Group Dividends

  Latest Previous
  Final Interim
Ex-Div 08-Nov-18 22-Mar-18
Paid 30-Nov-18 12-Apr-18
Amount 3.84p 1.76p

Trades for 12-Nov-2018

Time Volume / Share Price
16:50 4,847 @ 923.62p
16:37 9,000 @ 925.00p
16:37 9,000 @ 925.00p
16:37 8,554 @ 925.00p
16:35 34,901 @ 925.00p

Clinigen Group Key Personnel

CEO Shaun Edward Chilton
CFO Martin Abell

Top of Page